Abstract
Till date, several studies have reported magnetic drug targeting as well as passive drug delivery. In this study, the passive characteristic of PEGylated carriers with a neutral surface charge rather than chitosan (CS)-based nanoparticles (NPs) with a positive charge was proved using molecular docking. The complete and without flaw stealth CS-coated magnetic NPs (mNPs) loaded with an anticancer drug for intravenous drug delivery were prepared using a modified ionic-crosslinking method. The physicochemical properties of the prepared magnetic-CS NPs were characterized in detail. The transmission electron micrographs of NPs showed an uniform particle morphology with an average diameter of smaller than 10 nm. The average IC50 values of the drug in PEGylated NPs for MCF-7 and PC-12 cells were 44 and 72 µM, respectively. The fabricated stealth NPs can increase the cytotoxicity and cell permeability of formulation that may release the entire drug in targeted shape to objective tissues that were firstly proved by molecular docking. This strategy showed a reduction in uptaking of mNPs by the reticuloendothelial system, which indeed increases the concentration of therapeutic agent(s) in the target site.
Similar content being viewed by others
References
Chen T-J, Cheng T-H, Chen C-Y, Hsu S C, Cheng T-L, Liu G-C et al 2009 JBIC, J. Biol. Inorg. Chem. 14 253
Azandaryani A H, Kashanian S and Jamshidnejad-Tosaramandani T 2019 Curr. Pharm. Biotechnol. 20 526
Chandra S, Noronha G, Dietrich S, Lang H and Bahadur D 2014 J. Magn. Magn. Mater. 380 7
Yang H Y, Li Y and Lee D S 2018 Adv. Ther. 1 1800011
Chen J-P, Yang P-C, Ma Y-H and Wu T 2011 Carbohydr. Polym. 84 364
Abakumov M A, Nukolova N V, Sokolsky-Papkov M, Shein S A, Sandalova T O, Vishwasrao H M et al 2015 Nanomed.: Nanotechnol., Biol. Med. 11 825
Berry C C 2009 J. Phys. D: Appl. Phys. 42 224003
Wang W, Jing Y, He S, Wang J-P and Zhai J-P 2014 Colloids Surf. B 117 449
Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R and Hubalek J 2010 Pharmacol. Res. 62 144
Park J H, Saravanakumar G, Kim K and Kwon I C 2010 Adv. Drug Deliv. Rev. 62 28
Azandaryani A H, Kashanian S, Shahlaei M, Derakhshandeh K, Motiei M and Moradi S 2019 Pharm. Res. 36 62
Corbet C, Ragelle H, Pourcelle V, Vanvarenberg K, Marchand-Brynaert J, Préat V et al 2016 J. Control. Release 223 53
Baharifar H, Khoobi M, Bidgoli S A and Amani A 2020 Int. J. Biol. Macromol. 143 181
Wathoni N, Rusdin A, Febriani E, Purnama D, Daulay W, Azhary S Y et al 2019 J. Pharm. Bioallied Sci. 11 619
Blanco E, Shen H and Ferrari M 2015 Nat. Biotechnol. 33 941
Patitsa M, Karathanou K, Kanaki Z, Tzioga L, Pippa N, Demetzos C et al 2017 Sci. Rep. 7 775
Zhang T, Zhou S, Hu L, Peng B, Liu Y, Luo X et al 2018 Drug Deliv. Transl. Res. 8 602
Oh N and Park J-H 2014 Int. J. Nanomed. 9 51
Vieira A C, Chaves L L, Pinheiro M, Lima S A C, Ferreira D, Sarmento B et al 2018 Artif. Cells Nanomed. Biotechnol. 46 653
Feinberg H, Park-Snyder S, Kolatkar A R, Heise C T, Taylor M E and Weis W I 2000 J. Biol. Chem. 275 21539
Fraser I P, Koziel H and Ezekowitz R A B (eds) 1998 Semin. Immunol. 10 363
Lodhia J, Mandarano G, Ferris N, Eu P and Cowell S 2010 Biomed. Imaging Interv. J. 6 e12
Graczyk H, Bryan L C, Lewinski N, Suarez G, Coullerez G, Bowen P et al 2015 J. Aerosol Med. Pulm. Drug Deliv. 28 43
Nikandish N, Hosseinzadeh L, Derakhshandeh K and Hemmati Azandaryani A 2016 Iran. J. Pharm. Res. 15 403
Azandaryani A H, Kashanian S and Derakhshandeh K 2017 Pharm. Res. 34 2798
Shameli K, Bin Ahmad M, Jazayeri S D, Sedaghat S, Shabanzadeh P, Jahangirian H et al 2012 Int. J. Mol. Sci. 13 6639
Dey S K, Mandal B, Bhowmik M and Ghosh L K 2009 Braz. J. Pharm. Sci. 45 585
Khanmohammadi M, Ashori A, Kargosha K and Garmarudi A B 2007 J. Surfactants Deterg. 10 81
Mikhaylova M, Kim D K, Bobrysheva N, Osmolowsky M, Semenov V, Tsakalakos T et al 2004 Langmuir 20 2472
Hong P Z, Li S D, Ou C Y, Li C P, Yang L and Zhang C H 2007 J. Appl. Polym. Sci. 105 547
Li G-Y, Jiang Y-R, Huang K-L, Ding P and Chen J 2008 J. Alloys Compd. 466 451
Safari J and Zarnegar Z 2013 J. Chem. Sci. 125 835
Ofner C M, Pica K, Bowman B J and Chen C-S 2006 Int. J. Pharm. 308 90
Wang H-X, Zuo Z-Q, Du J-Z, Wang Y-C, Sun R, Cao Z-T et al 2016 Nano Today 11 133
Salatin S and Yari Khosroushahi A 2017 J. Cell. Mol. Med. 21 1668
Gordon S 2002 Cell 111 927
Han Y, Zhao L, Yu Z, Feng J and Yu Q 2005 Int. Immunopharmacol. 5 1533
Li S-D and Huang L 2009 Biochim. Biophys. Acta (BBA), Biomembr. 1788 2259
Xue Y, Balmuri S R, Patel A, Sant V and Sant S 2018 Drug Deliv. Transl. Res. 8 357
Meyer O, Kirpotin D, Hong K, Sternberg B, Park J W, Woodle M C et al 1998 J. Biol. Chem. 273 15621
Farjadian F, Ghasemi S and Mohammadi-Samani S 2016 Int. J. Pharm. 504 110
Luong D, Kesharwani P, Deshmukh R, Amin M C I M, Gupta U, Greish K et al 2016 Acta Biomater. 43 14
Arranja A, Gouveia L F, Gener P, Rafael D F, Pereira C, Schwartz S et al 2016 Int. J. Pharm. 501 180
Mehrabi M, Esmaeilpour P, Akbarzadeh A, Saffari Z, Farahnak M, Farhangi A et al 2016 Turk. J. Med. Sci. 46 567
Acknowledgements
We express our sincere thanks to the deputy of Iran National Science Foundation (INSF) of the presidency of the Islamic Republic of Iran, vice presidency for science and technology under the Project 91003523.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
HEMATI AZANDARYANI, A., KASHANIAN, S., BAHRAMI, Y. et al. Stealth cross-linked polymeric nanoparticles for passive drug targeting: a combination of molecular docking and comprehensive in vitro assay. Bull Mater Sci 43, 232 (2020). https://doi.org/10.1007/s12034-020-02166-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12034-020-02166-8